Background: Staphylococcus aureus has been proposed as a disease modifier of allergic rhinitis (AR) severity. Although several studies have investigated the prevalence of nasal carriage of S. aureus in healthy controls and AR patients, data from Thailand is scarce.
Introduction
The prevalence of allergic rhinitis (AR) has escalated dramatically in recent years. 1 The seriousness of the disease has also increased, with a commensurate increase in adverse impact on quality of life. Many recent studies have focused on the relationship between Staphyloccoccus aureus (S. aureus) and allergic diseases, such as asthma, atopic dermatitis, and AR. [1] [2] [3] [4] [5] S. aureus is considered to be normal flora. Approximately 25% of the populations are S. aureus carriers, and many factors may alter the prevalence of the carrier stage of S. aureus, including ethnicity, age, gender, and body site. 3, [6] [7] [8] Moreover, S. aureus infection can develop into a life-threatening condition depending on the Staphylococcal superantigens (SA) that induce inflammatory immune response. In allergic disease, SA increases the sensitivity to antigen and decreases T-cell response to steroid, which may worsen disease severity. 1 Several studies have reported on the prevalence of nasal carriage of S. aureus in healthy controls and in AR patients. Those studies found the prevalence of nasal carriage of S. aureus to be significantly higher among AR patients compared to healthy controls, but no information about the pathogenesis was reported. 2, 9, 10 Very little is known about the prevalence of this condition in healthy controls and in AR patients in Thailand.
Material and methods

Study population
This prospective study enrolled non-AR healthy controls and confirmed AR aged 18-60 years who attended the Division of Rhinology & Allergy, Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand during the June 2013 and December 2013 study period. Siriraj Hospital is Thailand's largest national tertiary referral center. The protocol for this study was approved by the Siriraj Institutional Review Board (SIRB) (COA no. 408/ 2555(EC2)), and all participants provided written informed consent.
Participants were classified into either the healthy control group or the AR group. All participants were non-smoking, and all patients had normal anterior and posterior rhinoscopy on physical examination. Healthy control group patients had no history of symptoms suggestive of chronic rhinitis, such as rhinorrhea, sneezing, nasal congestion, and/or itching. AR group patients were confirmed by clinical history of rhinorrhea, sneezing, nasal congestion, and itching for at least one hour on most days, as well as by positive skin prick test for any specific allergen(s). Skin prick test was classified into 5 groups, including HDM (house dust, mite), pets (cat, dog), household insects (cockroach, mosquito, housefly, ant), pollens (Bermuda grass, paragrass, sugar cane, sedge, careless weed, typha, mixed grasses), and molds (Cladosporium, Penicillium, Aspergillus, mixed mold). Subjects meeting one or more of the following criteria were excluded: being a healthcare provider; having comorbid disease(s) (e.g., chronic rhinosinusitis, asthma, and/or atopic rhinitis); previous nasal/sinus operation; and/or, prior use of any antibiotics within four weeks.
Study protocol
For detection of nasal carriage of S. aureus, the specimen was collected from the nasal vestibule, including head of inferior turbinate using nasal swab (rayon-tipped swab, BBL™ CultureSwab™, Becton Dickinson, Franklin Lakes, NJ, USA). The contact time was at least 3 seconds using the technique developed from Centers for Disease Control (CDC) guideline, 2000. The specimen was then sent to our laboratory for culture within 1 hour. The laboratory system at our center adheres to the standards of the Clinical and Laboratory Standards Institute (CLSI) 2013. 11 All AR patients were assessed for disease severity using Allergic Rhinitis and its Impact on Asthma (ARIA) guideline, and visual analog scale (VAS) for evaluation of nasal symptom severity. Quality of life was assessed by two validated questionnaires, including the Thai version of the 36-Item Short Form Health survey (SF-36), and the Rhinoconjunctivitis Quality of Life questionnaires (RCQ-36). The SF-36 has 8 domains, including physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and Accordingly, the aim of this study was to determine the prevalence of nasal carriage of S. aureus in AR patients compared with healthy controls in Thailand. The secondary objective was to identify factors significantly associated with AR severity in patients positive for nasal carriage of S. aureus. mental health. The RCQ-36 also has 8 domains, including rhinitis symptoms, eye symptoms, other symptoms, physical functioning, role limitations, sleep, social functioning, and emotions. The relationship between nasal carriage of S. aureus in AR and AR disease severity was analyzed.
Statistical analysis
SPSS Statistics version 18 (SPSS, Inc., Chicago, IL, USA) was used to perform all statistical analyses. Quantitative data are presented as mean ± standard deviation, and qualitative data are described as frequency. T-test and chi-square test were used for quantitative and qualitative data comparison, respectively, between AR and healthy subjects. A p-value less than 0.05 was regarded as being statistically significant.
Results
Two hundred participants were enrolled in this study. Subjects were equally divided into the healthy control group or the AR group. In the healthy control group, there were 71 females and 29 males, with a mean age of 41.9 ± 11.4 years. In the AR group, there were 63 females and 37 males, with a mean age 40.0 ± 12.2 years ( 
Rate of nasal carriage of S. aureus
In the healthy control group, nasal swab cultures were positive for S. aureus in 20 of 100 control subjects. In the AR group, nasal swab cultures were positive for S. aureus in 21 of 100 patients. All of the positive cultures were methicillin-sensitive S. aureus (MSSA) in both groups. The prevalence of nasal carriage of S. aureus was not different between groups. (p = 0.86), ( Gender -Among the 63 females, cultures were negative in 55 patients and positive in 8 patients. Among the 37 males, cultures were negative in 24 patients and positive in 13 patients. The nasal carriage of S. aureus in male was statistically significant difference from female (p = 0.01), ( Table 3) . There was no statistical significance between the nasal carriage of S. aureus and the type of positive SPT allergen in both groups. There was no statistical significance between the nasal carriage of S. aureus and the severity of allergic rhinitis evaluated by ARIA Criteria. Health Survey (SF-36) Thai-version -There was no statistically significant difference between the severity of AR and nasal carriage of S. aureus. (p-value range: 0.08-0.95), ( Table 5 ).
The 36-Item Short Form
Discussion
Many recent studies have focused on the relationship between S. aureus and allergic diseases, such as asthma, atopic dermatitis, and AR. [1] [2] [3] [4] [5] Many factors are likely to alter the prevalence of the carrier stage of S. aureus, including ethnicity, age, gender, and body site. [6] [7] [8] 12, 13 Even though S. aureus is regarded as being normal flora, infection by S. aureus can be develop into a life-threatening condition. Infection capability and severity depends on the Staphylococcal superantigens that induce inflammatory immune response. In allergic disease, SA increases the sensitivity to antigen and decreases T-cell response to steroid, which may worsen disease severity. 1,2 Several factors have been described as causing an increase in the nasal carriage rate among AR patients. First, inflamed nasal mucosa in AR patients may provide better nutrients. 14 Second, nasal symptoms, such as rhinorrhea and sneezing, could increase finger to nose contact.
The worldwide nasal carriage rate of S. aureus is approximately 20-30%. Among Asian countries, the carriage rate is 23% in China, 35.7% in Japan, 9.1% in Pakistan, 23.4% in Malaysia, 24.1% in Taiwan, and 29.4% in India. 8, 12 The two studies conducted in Thailand, both of which had study populations consisting of university students, found prevalence rates of 15.0% and 27.7%, respectively. 15, 16 The carriage rate in our study was approximately 20% among healthy controls, which is similar to the rate worldwide and in Asia.
The nasal carriage rate of S. aureus among AR patients in this study was not significantly higher than the rate among healthy controls (21% vs, 20%, respectively), which was inconsistent with previous studies. 2, 9, 10 Riechelmann, et al. 2 and Shiomori, et al. 9 reported the prevalence of nasal carriage of S. aureus in AR patients to be higher than in the control group. Moreover and in contrast to our study, the nasal symptom score in those studies was significantly higher in positive culture patients than in negative culture patients.
The difference in the prevalence of nasal carriage of S. aureus between the present study and other studies can be explained by the nasal carriage pattern. It may be persistent or intermittent carriage. Still, there is no consensus regarding how many cultures should be taken to define persistent carriage. Specimen collection could also be another factor. The study of Riechelmann used the nasal lavages to assess the number of SA. 2 They discussed about the semi quantitative assessment of nasal SA colonization. But the pathophysiology of SA for allergic disease is the 'intracellular' SA, which acts as the superantigen. 5 This is the possibility of explanation of contradiction. Another hypothesis is the possibility of difference strain of SA of production of SA super antigen between Asia and European. Timing and techniques (nasal lavage versus nasal swab culture) might affect the yield of positive cultures.
Rhinoconjunctivitis Quality of Life questionnaires (RCQ-36) Thai-version -
There was no statistical significance between the severity of AR and nasal carriage of S. aureus. (p-value range: 0.23-0.92), ( Table 6 ). All of the 4 severity assessment tools suggested that there was no statistical significance between the severity of allergic rhinitis and the nasal carriage of S. aureus.
Healthy controls group
Age -Mean age was 41.9 ± 11.6 years among those with negative S. aureus culture, and 42.1 ± 10.9 years among those with positive S. aureus culture.
Gender -Among the 71 female controls, cultures were negative in 56 women, and positive in 15 women. Among the 29 male controls, cultures were negative in 24 men, and positive in 5 men.
Thus, nasal carriage was not relevant to age and sex in the healthy control group.
Conclusion
The prevalence of S. aureus in allergic rhinitis patients was not different from healthy controls in Thailand. The nasal carriage rate in healthy controls was about 20%, similar to the worldwide studies. No significant associations were found between evaluated factors and AR severity in AR patients with nasal carriage of S. aureus.
